Vetnostrum Animal Health Co., Ltd. (TPE:6936)

Market Cap	2.45B -10.4%
Revenue (ttm)	1.44B +6.6%
Net Income	137.43M -5.0%
EPS	1.89 -13.4%
Shares Out	72.80M
PE Ratio	17.85
Forward PE	n/a
Dividend	1.33 (3.95%)
Ex-Dividend Date	Jun 9, 2026

Volume	74,392
Open	33.65
Previous Close	33.70
Day's Range	33.55 - 34.05
52-Week Range	32.65 - 46.20
Beta	0.09
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 10, 2026

About Vetnostrum Animal Health

Vetnostrum Animal Health Co., Ltd. engages in the import, manufacture, and sale of animal medicines, health food, feed additives, and feed. It offers antibiotics, hormonal preparations, topical disinfectants, and drugs for anti-inflammatory, deworming, anti-fungal, antiprotozoal, etc; vitamins, minerals, and amino acids for regular supplementary; and non-medicated feed additives for swine, cattle and sheep, poultry, pet, and aquatic animals. The company was founded in 2012 and is based in Hsinchu City, Taiwan. Vetnostrum Animal Health Co., Ltd....

• Industry: Farm Products
• Sector: Consumer Staples
• Founded: 2012
• Employees: 195
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6936

Financial Performance

In 2025, Vetnostrum Animal Health's revenue was 1.42 billion, an increase of 9.43% compared to the previous year's 1.29 billion. Earnings were 128.85 million, a decrease of -5.68%.